National Institutes of Health
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing October 1, 2026.
Overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them…